Evidence map›Paper›PMID 31699777›Full record

ArticleGenes & development2019

Context-specific regulation of cell survival by a miRNA-controlled BIM rheostat.

Verena Labi, Siying Peng, Filippos Klironomos, Mathias Munschauer, Nicolai Kastelic, Tirtha Chakraborty, Katia Schoeler, Emmanuel Derudder, Manuela Martella, Guido Mastrobuoni and 9 more

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Overview of the Different Classes of Small RNAs During B-Cell Development.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  5. Article
  6. BCL-2 protein family: attractive targets for cancer therapy.Apoptosis : an international journal on programmed cell death · 2023
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. The RNA modification NNature immunology · 2020
    Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 3 countries.

Verena LabiMax Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.ORCID 0000-0001-7538-1520
Siying PengProgram of Cellular and Molecular Medicine, Children's Hospital, and Immune Disease Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
Filippos KlironomosMax Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.ORCID 0000-0003-2627-5662
Mathias MunschauerMax Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.ORCID 0000-0001-6143-4548
Nicolai KastelicMax Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.ORCID 0000-0001-6557-7378
Tirtha ChakrabortyProgram of Cellular and Molecular Medicine, Children's Hospital, and Immune Disease Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
Katia SchoelerDivision of Developmental Immunology, Biocenter, Medical University of Innsbruck, Innsbruck 6020, Austria.
Emmanuel DerudderMax Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.ORCID 0000-0003-1421-4045
Manuela MartellaInstitute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, Eberhard-Karls-University, Tübingen 72076, Germany.ORCID 0000-0002-4269-6902
Guido MastrobuoniMax Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.ORCID 0000-0003-4509-1295
Luis R Hernandez-MirandaMax Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.ORCID 0000-0002-0498-708X
Ines LahmannMax Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.
Christine KocksMax Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.ORCID 0000-0003-1749-3334
Carmen BirchmeierMax Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.ORCID 0000-0002-2041-8872
Stefan KempaMax Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.ORCID 0000-0002-0696-9299
Leticia Quintanilla-Martinez de FendInstitute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, Eberhard-Karls-University, Tübingen 72076, Germany.ORCID 0000-0001-7156-5365
Markus LandthalerMax Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.ORCID 0000-0002-1075-8734
Nikolaus RajewskyMax Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.ORCID 0000-0002-4785-4332
Klaus RajewskyMax Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin-Buch 13125, Germany.ORCID 0000-0002-6633-6370
Max Delbrück Center · DEBoston Children's Hospital · USBernstein Center for Computational Neuroscience Tübingen · DEInnsbruck Medical University · AT

Funding

Role of RNA silencing in B cell development and functionR01AI064345 · NIAID · IMMUNE DISEASE INSTITUTE, INC. · PI RAJEWSKY, KLAUS · 2005 to 2009
$2.9M
NIAID NIH HHS R01 AI064345
6 · The paper itself

Abstract

Knockout of the ubiquitously expressed miRNA-17∼92 cluster in mice produces a lethal developmental lung defect, skeletal abnormalities, and blocked B lymphopoiesis. A shared target of miR-17∼92 miRNAs is the pro-apoptotic protein BIM, central to life-death decisions in mammalian cells. To clarify the contribution of miR-17∼92:Bim interactions to the complex miR-17∼92 knockout phenotype, we used a system of conditional mutagenesis of the nine

Indexed as

3' Untranslated RegionsAnimalsBcl-2-Like Protein 11B-LymphocytesCell SurvivalGene Expression Regulation, DevelopmentalGene Knockout TechniquesHematopoiesisLungMiceMicroRNAsMutationStress, Physiological3' Untranslated RegionsBcl-2-Like Protein 11MicroRNAsMIRN17-92 microRNA, mouseapoptosisB cellsBIMlung developmentmiR-17∼92seed match mutation

Identifiers

PMID31699777
PMCPMC6942046
OpenAlexW2984021980

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.